Abrdn World Healthcare Fund (NYSE:THW) Trading 0.6% Higher – Time to Buy?

Shares of Abrdn World Healthcare Fund (NYSE:THW) were up 0.6% during mid-day trading on Wednesday . The stock traded as high as $13.60 and last traded at $13.48. Approximately 162,893 shares were traded during trading, an increase of 23% from the average session volume of 132,066 shares. The stock had previously closed at $13.40.

Abrdn World Healthcare Fund Stock Performance

The business’s fifty day moving average price is $12.67 and its 200 day moving average price is $12.56.

Abrdn World Healthcare Fund Announces Dividend

The business also recently announced a monthly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 23rd were issued a dividend of $0.1167 per share. The ex-dividend date of this dividend was Tuesday, June 23rd. This represents a c) annualized dividend and a yield of 10.4%.

Institutional Trading of Abrdn World Healthcare Fund

Institutional investors have recently added to or reduced their stakes in the stock. Advisory Services Network LLC bought a new stake in shares of Abrdn World Healthcare Fund in the 3rd quarter valued at $43,000. Ameriflex Group Inc. acquired a new stake in shares of Abrdn World Healthcare Fund during the 3rd quarter worth approximately $79,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Abrdn World Healthcare Fund during the 2nd quarter worth approximately $113,000. Mercer Global Advisors Inc. ADV bought a new stake in shares of Abrdn World Healthcare Fund in the 4th quarter valued at $157,000. Finally, HighTower Advisors LLC bought a new stake in shares of Abrdn World Healthcare Fund in the 4th quarter valued at $168,000.

About Abrdn World Healthcare Fund

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.